Glucose Health, Inc. Fiscal 2021 Annual Report

Rhea-AI Summary

Glucose Health, Inc. (OTC: GLUC) reported significant growth in its Fiscal 2021 Annual Report. Revenues surged by 98% to $953,681, with gross profits up 136% to $410,042. The company achieved a debt-free status, with total liabilities reduced to $9,554 from $380,652 in the previous year. New product launches, including the highly successful GLUCODOWN® Cherry, contributed to this growth. For Fiscal 2022, Glucose Health plans to strengthen distribution partnerships and launch a new ready-to-drink beverage aimed at the 45+ demographic.

Positive

• Fiscal 2021 revenue increased by 98% to $953,681.
• Gross profit rose 136% to $410,042.
• Total liabilities decreased significantly to $9,554.
• Successful launch of new GLUCODOWN® flavors with strong initial sales.

Negative

• None.

BENTONVILLE, AR, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted today at OTCMarkets.com. In fiscal 2021, Glucose Health, Inc. more than doubled gross profits, effectively doubled revenue, and achieved the unique status of a debt free, emerging growth, company.

• Fiscal 2021 Revenue of $953,681 vs. $480,713 for Fiscal 2020 = a 98% increase.
• Fiscal 2021 Gross Profit of $410,042 vs. $173,545 for Fiscal 2020 = a 136% increase.
• Fiscal 2021 Total Liabilities of $9,554 vs. $380,652 for Fiscal 2020

During fiscal 2021, Glucose Health, Inc. introduced four new GLUCODOWN® Diabetic Friendly, Blood Sugar Maintenance "enhanced water" flavors, complementing its existing four GLUCODOWN® iced tea flavors, launched in the fourth quarter of 2017.  New GLUCODOWN® Cherry, in particular, outsold each of the three "enhanced water" flavors and also outsold all four established iced tea flavors, at Amazon. Within weeks, GLUCODOWN® Cherry sold out of its entire initial production run, at Amazon.

For fiscal 2022, the Company will build upon its success at Amazon and significantly ramp up sales and marketing partnerships to expand distribution of GLUCODOWN® with new brick-and-mortar retailers. Additionally, in fiscal 2022, Glucose Health, Inc. will launch an innovative new brand; a ready-to-drink, delicious and healthy beverage, specifically formulated to address the nutritional needs of the under-served 45+ consumer.

About Glucose Health, Inc. (OTC: GLUC)

Manufactured by Glucose Health, Inc., the GLUCODOWN® brand is defining a new beverage industry category – functional, diabetic friendly, beverages. By specializing in producing healthy and delicious beverages, nutritionally appropriate1 for the nation's 100+ million2 pre and Type-2 diabetics, and additionally in 2022, launching a new healthy and delicious ready-to-drink beverage formulated to meet the nutritional needs of 45+ consumers, Glucose Health, Inc. is uniquely positioned among all emerging beverage companies in America. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.

For more GLUC news visit www.glucosehealthinc.com
Like us on Facebook at www.facebook.com/glucodown

1 For citations visit www.glucodown.com/clinical-data
2 National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services

Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

FAQ

What were Glucose Health's revenue and gross profit for Fiscal 2021?

Glucose Health reported revenue of $953,681 and gross profit of $410,042 for Fiscal 2021.

What is the total liability of Glucose Health as of Fiscal 2021?

As of Fiscal 2021, Glucose Health's total liabilities were $9,554.

What new products did Glucose Health launch in Fiscal 2021?

In Fiscal 2021, Glucose Health launched four new GLUCODOWN® Diabetic Friendly flavors, including the popular GLUCODOWN® Cherry.

What are Glucose Health's plans for Fiscal 2022?

For Fiscal 2022, Glucose Health plans to ramp up distribution partnerships and launch a new ready-to-drink beverage targeting consumers aged 45 and over.